Extrahepatic, cell-specific delivery of LNPs through competitive inhibition of ApoE-mediated uptake
Joshua C. Bufton, Thomas Green, Angharad Walters, Adam Willis Perriman, Ben M. Carter
This paper develops NanoPilot, a modular fusion protein platform to redirect lipid nanoparticles (LNPs) away from the liver and toward specific cell types, improving transfection efficiency in T-cells and reducing off-target uptake.
bioRxiv · Aug 4, 2026 · PreprintBiochemistry